Soluble CD163 correlates with lipid metabolic adaptations in human type 1 diabetes patients during ketoacidosis.
J Diabetes Investig 2018 May 26. Epub 2018 May 26.
Department of Hepatology and Gastroenterology, Aarhus University, Aarhus C, Denmark.
Background: Diabetic ketoacidosis (DKA) is associated with inflammation and increased lipolysis. The macrophage activation marker soluble CD163 (sCD163) is associated with obesity, non-alcoholic fatty liver disease, and type-2 diabetes. We aimed to investigate whether sCD163 correlates with, key elements of lipolysis in type-1 diabetes (DM1) patients during mild diabetic ketoacidosis. Read More